Daiwa Securities Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 1393 |
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1400 |
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 1428 |
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 1419 |
|
2021
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 1452 |
|
2021
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1340 |
|
2021
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1220 |
|
2021
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 1234 |
|
2020
Q4 | $1K | Sell |
10
-17
| -63% | -$1.7K | ﹤0.01% | 1214 |
|
2020
Q3 | $2K | Hold |
27
| – | – | ﹤0.01% | 1139 |
|
2020
Q2 | $2K | Hold |
27
| – | – | ﹤0.01% | 1151 |
|
2020
Q1 | $2K | Hold |
27
| – | – | ﹤0.01% | 1158 |
|
2019
Q4 | $2K | Hold |
27
| – | – | ﹤0.01% | 1160 |
|
2019
Q3 | $3K | Buy |
27
+5
| +23% | +$556 | ﹤0.01% | 1098 |
|
2019
Q2 | $2K | Hold |
22
| – | – | ﹤0.01% | 1140 |
|
2019
Q1 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 1130 |
|